Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
iThera Medical logo — Biomarkers, in living color.

iThera Medical

Biomarkers, in living color.

Founded 2010 Germany Germany 65 employees Series D Total: $15.95M Biotechnology, Health Care

General Information

Company Name iThera Medical
Founded Year 2010
Location Germany Germany
Employees 65
Industries Biotechnology, Health Care
Funding Stage Series D
Business Model B2B, Platform
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with iThera Medical. To contact iThera Medical, visit ithera-medical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does iThera Medical compare?

A PDF of iThera Medical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting iThera Medical soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About iThera Medical

iThera Medical, founded in 2010 and headquartered in Germany, is revolutionizing the Biotechnology and Health Care sectors with its pioneering technology, Multispectral Optoacoustic Tomography (MSOT). Their slogan, "Biomarkers, in living color," encapsulates their mission to enhance biomedical imaging. MSOT leverages the photoacoustic effect to provide real-time, in vivo visualization and quantification of anatomical, functional, and molecular data. This technology is pivotal in studying disease mechanisms and drug properties at a molecular level.

iThera Medical's innovation has translated MSOT for clinical applications, offering promising diagnostic solutions for diseases such as melanoma and breast cancer. Their recent Series D investment of €13.00M in December 2022, led by investors like Bayern Kapital and TRUMPF Venture, underscores strong market confidence. With its cutting-edge solutions and strategic industry backing, iThera Medical is poised for significant impact in medical diagnostics.

Business keywords: Multispectral Optoacoustic Tomography, Photoacoustic Effect, Biomedical Imaging Systems, Deep Tissue Imaging, Real-Time Imaging, Molecular Imaging, Pharmacokinetics Analysis, Biodistribution Studies, Disease Process Visualization, Preclinical Applications, Clinical Diagnostics, Diagnostic Tools, Cancer Diagnostics, Inflammatory Disease Analysis, Neuromuscular Disease Imaging

Services & Products

Development of advanced sensing and imaging technology
Providing insights across various sectors
Non-invasive observation and measurement solutions

Target Customers

Healthcare professionals Biomedical researchers Agriculture and food industry Environmental scientists Industrial sector

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series D €13.00M 4
Bayern Kapital Fluxunit Mey Capital Matrix
Bayern Kapital, Fluxunit +2
01 Dec 2022
Grant €890.00K 1
Horizon 2020 FTI (Fast Track to Innovation)
01 Aug 2018
Grant €2.06M 1
Horizon 2020 FTI (Fast Track to Innovation)
01 Nov 2015
Series A Undisclosed 3
Mey Capital Matrix BayBG VENTURE CAPITAL
Mey Capital Matrix, BayBG VENTURE CAPITAL +1
01 Nov 2011
Spinout Undisclosed 1
Helmholtz Association - Helmholtz Gemeinschaft
01 Jan 2010

iThera Medical Alternatives & Competitors

View All Alternatives
iThera Medical vs
Scinvivo B.V.
Scinvivo B.V. The Netherlands

Optical biopsy for bladder cancer diagnostics

Venture round
17 employees
Biotechnology, Health Care
Compare iThera Medical vs Scinvivo B.V.
iThera Medical vs
BillionToOne
BillionToOne United States

We push the boundaries of molecular diagnostics through quantitative technologies.

IPO
815 employees
Biotechnology, Health Care
Compare iThera Medical vs BillionToOne
iThera Medical vs
Bio-Rad Laboratories
Bio-Rad Laboratories United States

Powering Possibilities. Saving Lives Together.

Debt Financing
9366 employees
Biotechnology, Health Care
View all alternatives

FAQ About iThera Medical

Biomarkers, in living color.
iThera Medical was founded in 2010.
iThera Medical is headquartered in Germany.
iThera Medical operates in Biotechnology and Health Care. Its work centres on Multispectral Optoacoustic Tomography, Photoacoustic Effect, Biomedical Imaging Systems and Deep Tissue Imaging. Its customers include Healthcare professionals, Biomedical researchers and Agriculture and food industry.
iThera Medical has a B2B and Platform business model. Its revenue comes from Product Sales, Service Fee and Licensing.
iThera Medical has approximately 65 employees.
iThera Medical has completed 5 funding rounds, raising a total of $15.95M. The latest funding stage is Series D.
iThera Medical offers: Development of advanced sensing and imaging technology, Providing insights across various sectors, Non-invasive observation and measurement solutions.
Top alternatives and competitors to iThera Medical include Scinvivo B.V., BillionToOne, Bio-Rad Laboratories. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iThera Medical and Scinvivo B.V. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for iThera Medical, https://bouncewatch.com/company/ithera-medical, updated 28 May 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout